ZA200109850B - Quaternay ammonium derivatives, method for preparing same and pharmaceutical use. - Google Patents

Quaternay ammonium derivatives, method for preparing same and pharmaceutical use.

Info

Publication number
ZA200109850B
ZA200109850B ZA200109850A ZA200109850A ZA200109850B ZA 200109850 B ZA200109850 B ZA 200109850B ZA 200109850 A ZA200109850 A ZA 200109850A ZA 200109850 A ZA200109850 A ZA 200109850A ZA 200109850 B ZA200109850 B ZA 200109850B
Authority
ZA
South Africa
Prior art keywords
sub
pharmaceutical use
preparing same
ammonium derivatives
cartilage
Prior art date
Application number
ZA200109850A
Other languages
English (en)
Inventor
Jean-Claude Madelmont
Isabelle Giraud
Colette Nicolas
Jean-Claude Maurizis
Maryse Rapp
Monique Ollier
Pierre Renard
Daniel-Henri Caignard
Original Assignee
Servier Lab
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Inst Nat Sante Rech Med filed Critical Servier Lab
Publication of ZA200109850B publication Critical patent/ZA200109850B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D259/00Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200109850A 1999-06-23 2001-11-29 Quaternay ammonium derivatives, method for preparing same and pharmaceutical use. ZA200109850B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908020A FR2795412B1 (fr) 1999-06-23 1999-06-23 Nouveaux derives d'ammonium quaternaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200109850B true ZA200109850B (en) 2003-02-26

Family

ID=9547207

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109850A ZA200109850B (en) 1999-06-23 2001-11-29 Quaternay ammonium derivatives, method for preparing same and pharmaceutical use.

Country Status (21)

Country Link
US (2) US6759406B1 (xx)
EP (1) EP1185526B1 (xx)
JP (1) JP2003503407A (xx)
KR (1) KR20020016846A (xx)
CN (1) CN1370161A (xx)
AT (1) ATE276251T1 (xx)
AU (1) AU771865B2 (xx)
BR (1) BR0011943A (xx)
CA (1) CA2377154A1 (xx)
DE (1) DE60013818T2 (xx)
EA (1) EA004292B1 (xx)
ES (1) ES2231222T3 (xx)
FR (1) FR2795412B1 (xx)
HK (1) HK1048319A1 (xx)
HU (1) HUP0201552A3 (xx)
MX (1) MXPA01013148A (xx)
NO (1) NO20016267L (xx)
NZ (1) NZ516337A (xx)
PL (1) PL353032A1 (xx)
WO (1) WO2001000621A1 (xx)
ZA (1) ZA200109850B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627523C1 (de) 1996-07-09 1997-10-23 Alpha Calcit Fuellstoff Gmbh Verfahren zur Wiederverwertung von Füllstoffen und Streichpigmenten der Papier-, Pappe- und Kartonherstellung
FR2818641B1 (fr) * 2000-12-21 2004-03-05 Servier Lab Nouveaux derives de 1,1-dioxo-2h-1,2-benzothiazine 3-carboxamides, leur procede de preparation et les compositions pharmaceutiques que les contiennent
CN104987296B (zh) * 2006-10-03 2018-11-23 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的芥子类化合物及其相关化合物的前药
WO2008041059A1 (en) * 2006-10-03 2008-04-10 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates
FR2981849B1 (fr) * 2011-10-28 2014-01-03 Univ Claude Bernard Lyon Nanoparticules fonctionnalisees pour le ciblage des proteoglycanes et leurs applications
EP2639227A1 (en) * 2012-03-14 2013-09-18 Bracco Imaging S.p.A A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents
FR2989280B1 (fr) 2012-04-13 2017-02-24 Univ Claude Bernard Lyon Nanoparticules ultrafines comme agent de contraste multimodal
EP3177598B1 (en) 2014-07-28 2019-08-28 Institut National de la Sante et de la Recherche Medicale (INSERM) Macrocyclic complexes, their process of preparation and use as pet imaging agents
FR3072281B1 (fr) 2017-10-13 2020-12-04 Nh Theraguix Nanovecteurs et utilisations, en particulier pour le traitement de tumeurs
GB202102243D0 (en) 2021-02-17 2021-03-31 Royal Veterinary College New compounds and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
IL115113A (en) * 1995-08-31 2002-11-10 Israel State 3-carbamoyloxy pyridinium derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2231222T3 (es) 2005-05-16
US6759406B1 (en) 2004-07-06
PL353032A1 (en) 2003-10-06
NZ516337A (en) 2003-11-28
HK1048319A1 (zh) 2003-03-28
CA2377154A1 (fr) 2001-01-04
WO2001000621A1 (fr) 2001-01-04
EA004292B1 (ru) 2004-02-26
EP1185526B1 (fr) 2004-09-15
EP1185526A1 (fr) 2002-03-13
US7008613B2 (en) 2006-03-07
US20040208822A1 (en) 2004-10-21
AU771865B2 (en) 2004-04-01
HUP0201552A2 (en) 2002-08-28
HUP0201552A3 (en) 2004-03-01
FR2795412A1 (fr) 2000-12-29
FR2795412B1 (fr) 2001-07-13
ATE276251T1 (de) 2004-10-15
CN1370161A (zh) 2002-09-18
DE60013818T2 (de) 2005-11-17
KR20020016846A (ko) 2002-03-06
NO20016267D0 (no) 2001-12-20
BR0011943A (pt) 2002-05-14
AU5989300A (en) 2001-01-31
DE60013818D1 (de) 2004-10-21
MXPA01013148A (es) 2004-08-19
JP2003503407A (ja) 2003-01-28
EA200200041A1 (ru) 2002-06-27
NO20016267L (no) 2002-01-30

Similar Documents

Publication Publication Date Title
FI93831B (fi) Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita
DE602005005240D1 (de) 4'-C-substituierte 2-Haloadenosinderivate
KR870007163A (ko) 질소함유 융합 헤테로 사이클릭 화합물의 제조방법
ZA200109850B (en) Quaternay ammonium derivatives, method for preparing same and pharmaceutical use.
DE3776433D1 (de) Antimikrobielle mittel.
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
EP0259835A3 (en) Pyridazinone derivatives
EA199900754A1 (ru) Способ получения замещенного тиазолидиндиона
DE3586340D1 (de) Stickstoff enthaltende heterozyklische verbindungen.
ATE509911T1 (de) Verbindungen, die sich an die kleine furche von dna binden
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
HUT37863A (en) Fungicides and process for production of the beta naftil-alkyl-amin derivatives that can be applied as reagent
KR920014809A (ko) 트리플루오로메틸 1-카바 (1-데티아)세펨
KR840002360A (ko) 이미다졸 카르복시 유도체의 제조방법
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
ATE144770T1 (de) Dihydropyridinderivate und verfahren zu ihrer herstellung
ES8103082A1 (es) Procedimiento de preparacion de nuevos derivados pirido (3,4-e)-as-triazinos acilados y de sus sales de acicion aci-da de los mismos
KR890003690A (ko) 우레아 유도체
KR850003715A (ko) 5-아실-2(1h)-피리디논의 알콕시이미노 에테르 유도체의 제조방법
ATE239707T1 (de) 2-phenylpyridine-derivate und verfahren zu deren herstellung
DE50013499D1 (de) Herbizide 5-chlordifluormethyl-1, 3, 4-thiadiazol-2-yl-oxyacetanilide
KR830009059A (ko) 구아니딘 유도체의 제조방법
UA39157C2 (uk) Спосіб одержання похідних 2-арил-3-метил-4-оксо-3,4-дигідрохіназоліну та похідні 7-азабензонорборнену як проміжні сполуки
MX9706123A (es) Derivados de pirazolil-benzoilo.